Related Experiment Video
Updated: Sep 12, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Blood pressure load associated with progressive kidney function decline in biopsy-proven atherosclerotic chronic
Hiroki Nobayashi1, Go Kanzaki2, Haruki Mae1
1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan.
Insights
Elevated blood pressure (BP) load, even with normal office BP readings, significantly accelerates chronic kidney disease (CKD) progression. Comprehensive 24-hour ambulatory BP monitoring (ABPM) is vital for managing CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Hypertension Research
Background:
- Hypertension is a primary driver of chronic kidney disease (CKD) progression.
- The specific impact of elevated blood pressure (BP) load, particularly when office BP readings are normal, remains insufficiently understood.
- This study investigates the influence of elevated BP load in biopsy-proven CKD patients with normal office BP.
Purpose of the Study:
- To determine the impact of elevated blood pressure (BP) load in patients with biopsy-proven chronic kidney disease (CKD) and normal office BP.
- To compare outcomes between patients with isolated BP load elevation, hypertension, and normotension.
- To identify BP load elevation as a risk factor for CKD progression.
Main Methods:
- Retrospective cohort study involving 57 patients with histologically confirmed atherosclerotic CKD.
- Utilized 24-hour ambulatory BP monitoring (ABPM) and kidney biopsy data.
- Classified patients into normotension, isolated BP load elevation, and hypertension groups.
Main Results:
- Patients with isolated BP load elevation and hypertension exhibited significantly higher rates of adverse kidney events compared to the normotension group (p < 0.01).
- After adjusting for confounding factors, isolated BP load elevation remained a significant predictor of adverse kidney outcomes (hazard ratio, 9.25).
- A sustained decline in estimated glomerular filtration rate (eGFR) of ≥30% within 3 years was the primary outcome measure.
Conclusions:
- Isolated BP load elevation is a significant risk factor for CKD progression, even when office BP is normal.
- Targeting BP load normalization may offer a therapeutic strategy for managing CKD.
- 24-hour ABPM is essential for comprehensive CKD assessment, revealing abnormalities missed by conventional BP measurements.
Background:
Hypertension is a major risk factor for the progression of chronic kidney disease (CKD). However, the impact of blood pressure (BP) load, especially when office BP is normal, remains unclear. Thus, we conducted a retrospective cohort study to elucidate the impact of elevated BP load in patients with biopsy-proven CKD, BP load elevation, and a normal office BP compared with normotensive patients with CKD but without BP load elevation and those with hypertension.
Methods:
We retrospectively analyzed patients with histologically confirmed atherosclerotic CKD who underwent kidney biopsy and 24-h ambulatory BP monitoring (ABPM). Patients were classified into normotension, isolated BP load elevation, and hypertension groups. The primary outcome was a ≥ 30% sustained decline in estimated glomerular filtration rate (eGFR) within 3 years.
Results:
A total of 57 patients were analyzed. The isolated BP load elevation and hypertension groups showed a significantly higher incidence of adverse kidney events than the normotension group (p < 0.01). After adjusting for confounding factors (age, sex, urinary protein, and Mayo Clinic Chronicity Score), the hazard for kidney outcomes remained significant in the isolated BP load elevation group (hazard ratio, 9.25; 95% confidence interval, 1.29-66.30).
Conclusions:
Isolated BP load elevation is a significant risk factor for CKD progression even in patients with normal office BP. Normalization of BP load may be a potential therapeutic target in patients with CKD. Comprehensive BP assessment using 24-h ABPM is crucial for CKD management, as it reveals clinically important abnormalities that conventional measurements may not capture.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations

